SCHEDULE: Susquehanna Group Takes 7.2% Stake in Medifast

A group of Susquehanna-affiliated entities has disclosed a 7.2% passive ownership stake in Medifast, Inc., totaling 785,606 shares.

Summary

• G1 Execution Services, LLC, Susquehanna Fundamental Investments, LLC, and Susquehanna Securities, LLC, collectively referred to as the Reporting Persons, have filed a Schedule 13G.
• The Reporting Persons collectively beneficially own 785,606 shares of Medifast, Inc. Common Stock, $0.001 par value per share.
• This aggregate ownership represents 7.2% of Medifast, Inc.'s outstanding common stock.
• Susquehanna Securities, LLC's beneficial ownership includes options to buy 695,200 shares.
• Medifast, Inc. had 10,938,000 shares outstanding as of June 30, 2025, as indicated in its Quarterly Report on Form 10-Q filed on August 4, 2025.
• The shares were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of Medifast, Inc.

Sentiment

Score: 6

Explanation: The filing indicates a significant passive investment by a group of affiliated entities, which can be viewed as a vote of confidence, though it does not imply active management involvement or strategic changes.

Positives

• A group of affiliated investment entities has acquired a significant 7.2% passive stake in Medifast, Inc., potentially signaling institutional investor interest and confidence in the company.

Negatives

• No specific negative information was disclosed in this passive ownership filing.

Risks

• The reporting persons disclaim beneficial ownership of shares owned directly by another reporting person within the affiliated group.

Future Outlook

This filing is a disclosure of passive ownership and does not contain any forward-looking statements or guidance regarding Medifast, Inc.'s future performance or strategic outlook.

Industry Context

This filing indicates a significant passive investment by a group of affiliated entities in Medifast, Inc., a company operating in the health and wellness industry. Such institutional investments can reflect broader investor sentiment or perceived value within the sector, though this specific filing does not provide direct commentary on industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: The disclosure of a significant passive stake by institutional investors may be viewed positively, potentially signaling increased institutional interest and liquidity in Medifast's stock.

Key Dates

Recommendation

The Schedule 13G filing indicates a significant passive ownership stake by a group of affiliated investment entities. While this demonstrates institutional interest in Medifast, Inc., the filing explicitly states the shares were acquired in the ordinary course of business and not for the purpose of influencing control. Therefore, it does not provide new fundamental information to warrant a change in investment thesis, suggesting a 'hold' recommendation for existing investors.

Keywords

Medifast, ownership, Schedule 13G, institutional investment, passive stake, G1 Execution Services, Susquehanna, common stock